Added to YB: 2025-08-21
Pitch date: 2025-08-19
BTMD [bullish]
biote Corp.
-12.17%
current return
Author Info
No bio for this author
Company Info
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Market Cap
$81.3M
Pitch Price
$3.04
Price Target
8.00 (+200%)
Dividend
N/A
EV/EBITDA
4.20
P/E
3.23
EV/Sales
0.85
Sector
Pharmaceuticals
Category
value
A Niche Play in Hormone Health with a Mispriced Growth Story - Biote Corp.
BTMD: Hormone therapy platform with 70% margins in growing niche (3.3% penetration). Trades at 4.4x EV/EBITDA, 7.5x PE. Repurchasing 25% of shares. Core pellet business declining 8.8% YoY despite high patient satisfaction, but supplements +30% YoY. Turnaround potential offers 165% upside if growth resumes.
Read full article (8 min)